Hypofractionated proton beam therapy for cT1-2N0M0 non-small cell lung cancer patients with interstitial lung disease
T Saito, K Ohnishi, H Ishikawa, M Nakamura… - Anticancer …, 2021 - ar.iiarjournals.org
Background/Aim: To evaluate the outcomes of proton beam therapy (PBT) for early-stage
non-small cell lung cancer (NSCLC) in patients with interstitial lung disease (ILD). Patients …
non-small cell lung cancer (NSCLC) in patients with interstitial lung disease (ILD). Patients …
[HTML][HTML] Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia
S Hashimoto, H Iwata, Y Hattori, K Nakajima… - Radiation …, 2022 - Springer
Background Interstitial pneumonia (IP) is a disease with a poor prognosis. In addition, IP
patients are more likely to develop lung cancer. Since IP patients frequently develop …
patients are more likely to develop lung cancer. Since IP patients frequently develop …
High-dose proton beam therapy for Stage I non–small-cell lung cancer
K Nihei, T Ogino, S Ishikura, H Nishimura - International Journal of …, 2006 - Elsevier
Purpose: To evaluate retrospectively the safety and efficacy of high-dose proton beam
therapy (PBT) for Stage I non–small-cell lung cancer (NSCLC). Methods and Materials …
therapy (PBT) for Stage I non–small-cell lung cancer (NSCLC). Methods and Materials …
Long-term Outcomes After Moderate Hypofractionated Proton Therapy for Centrally Located Non-small Cell Lung Cancer
M Nakamura, H Ishikawa, K Ohnishi, K Baba… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: To investigate the outcomes of patients with centrally located non-small-
cell lung cancer (NSCLC) treated with proton beam therapy (PBT) using moderate …
cell lung cancer (NSCLC) treated with proton beam therapy (PBT) using moderate …
[HTML][HTML] Early outcomes of patients with locally advanced non-small cell lung cancer treated with intensity-modulated proton therapy versus intensity-modulated …
YY Nathan, TA DeWees, C Liu, TB Daniels… - Advances in Radiation …, 2020 - Elsevier
Purpose There are very little data available comparing outcomes of intensity-modulated
proton therapy (IMPT) to intensity-modulated radiation therapy (IMRT) in patients with locally …
proton therapy (IMPT) to intensity-modulated radiation therapy (IMRT) in patients with locally …
Clinical outcomes and prognostic factors of high-dose proton beam therapy for peripheral stage I non-small-cell lung cancer
Y Hatayama, T Nakamura, M Suzuki, Y Azami, T Ono… - Clinical lung cancer, 2016 - Elsevier
Background The efficacy, toxicity, and prognostic factors of high-dose proton beam therapy
(PBT) for peripheral stage I non-small-cell lung cancer were assessed in this retrospective …
(PBT) for peripheral stage I non-small-cell lung cancer were assessed in this retrospective …
[HTML][HTML] Proton beam therapy for histologically or clinically diagnosed stage I non-small cell lung cancer (NSCLC): The first nationwide retrospective study in Japan
K Ohnishi, N Nakamura, H Harada, S Tokumaru… - International Journal of …, 2020 - Elsevier
Purpose To investigate the efficacy and safety of proton beam therapy (PBT) for the
treatment of stage I non-small cell lung cancer (NSCLC). Methods and Materials Six …
treatment of stage I non-small cell lung cancer (NSCLC). Methods and Materials Six …
[HTML][HTML] Clinical outcomes of pencil beam scanning proton therapy in locally advanced non-small cell lung cancer: propensity score analysis
N Kim, JM Noh, W Lee, B Park, H Pyo - Cancers, 2021 - mdpi.com
Simple Summary We analyzed the oncologic outcomes and toxicities after intensity-
modulated radiation therapy (IMRT) or pencil beam scanning proton therapy (PBSPT) in …
modulated radiation therapy (IMRT) or pencil beam scanning proton therapy (PBSPT) in …
[HTML][HTML] Prospective study investigating hypofractionated proton beam therapy in patients with inoperable early stage non-small cell lung cancer
K Yang, JM Noh, HY Park, H Yoo, SH Shin… - Frontiers in …, 2024 - frontiersin.org
Purpose To report the results of hypofractionated proton beam therapy (PBT) for the
treatment of early stage lung cancer in patients not suitable for surgical resection. Methods …
treatment of early stage lung cancer in patients not suitable for surgical resection. Methods …
Proton beam therapy in elderly patients with cT1-3N0M0 non-small cell lung cancer
M Nakamura, H Ishikawa, K Ohnishi, K Baba… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: To investigate the outcomes of elderly patients with cT1-3N0M0 non-small
cell lung cancer (NSCLC) undergoing proton beam therapy (PBT). Patients and Methods …
cell lung cancer (NSCLC) undergoing proton beam therapy (PBT). Patients and Methods …